More from Latest News

classified as:
  • News releases
subscribe

Neuro XXceptional: Celebrating exceptional women

Women scientists and clinicians are creators and changemakers, expanding the boundaries of human knowledge

 

The Neuro has launched Neuro XXceptional - an exciting new year-long video series featuring women who tell us what drove them to become scientists and clinicians, and what they love about their work. At The Neuro, these exceptional professionals are improving the lives of patients, helping us understand how the brain works and how to treat neurological disease.

...
Published: 8 Mar 2018

Canadian researchers open a new front in the fight against MS

By Ross Neitz, University of Alberta

A discovery led by scientists at the University of Alberta and McGill University is providing hope of a new therapeutic target in Multiple Sclerosis (MS) patients, which could one day be used to prevent the symptoms and progression of the disease.

...
Published: 8 Mar 2018

A near-universal way to measure enzyme inhibition

Researchers at McGill University have invented a new technique for measuring how quickly drugs interact with their molecular targets. The discovery provides scientists with a new way to investigate the effectiveness of drug candidates that might otherwise have been overlooked.

...
Published: 1 Mar 2018

McGill welcomes major injection of federal funds to support research

The federal government’s announcement of a major investment in research in Tuesday’s 2018 budget was welcomed by McGill University Principal and Vice-Chancellor Suzanne Fortier.   “I am delighted to see increased federal support for fundamental research,” Prof. Fortier said....
Published: 27 Feb 2018

The onset of Alzheimer’s disease: the importance of family history

You’re about to turn 60, and you’re fretting. Your mother has had Alzheimer’s disease since the age of 65. At what age will the disease strike you? A Canadian study published in JAMA Neurology shows that the closer a person gets to the age at which their parent exhibited the first signs of Alzheimer’s, the more likely they are to have amyloid plaques, the cause of the cognitive decline associated with the disease, in their brain.

...
Published: 26 Feb 2018

Building bridges: Ashukin program connects McGill Nursing students with Quebec Indigenous communities

By Christina Kozakiewicz, Ingram School of Nursing

Source: Med-e-News

...
Published: 23 Feb 2018

McGill Dobson Centre ranked among world’s top incubation programs

By Rosalie Nardelli

UBI Global has released its World University-linked Business Incubator and Accelerator Ranking and has placed the McGill Dobson Centre for Entrepreneurship in the eight position of the World Top Business Incubator – Managed by a University category.

...
Published: 23 Feb 2018

McGill-led genomics centres win $9.8 M, three-year funding support from Genome Canada

The McGill University and Génome Québec Innovation Centre and the Canadian Centre for Computational Genomics will receive a total of $9.8 million in funding over three years through Genome Canada awards announced Feb. 21.

...
Published: 21 Feb 2018

National study to shed light on aging

  by Brenda Branswell   Source: McGill News Magazine   Imagine getting a phone call asking if you’d like to take part in a study … for the next 20 years.   It’s a pitch that makes telemarketing look like child’s play.   So no wonder Christina Wolfson, BSc’76, MSc’78, PhD’85, a profess...
Published: 20 Feb 2018

Products derived from plants offer potential as dual-targeting agents for experimental cerebral malaria

Malaria, a life-threatening disease usually caused when parasites from the Plasmodium family enter the bloodstream of a person bitten by a parasite-carrying mosquito, is a severe health threat globally, with 200 to 300 million cases annually and 445,000 deaths in 2016.

...
Published: 20 Feb 2018

The Neuro joins neuroscience data sharing partnership

Canadian Open Neuroscience Platform will make disseminating and publishing data easier

Modern neuroscience research can produce massive amounts of data, which researchers can use to find patterns revealing anything from the first physiological signs of Alzheimer’s disease to a new drug target that could stop neurodegeneration. However, this data must be stored, processed, and distributed effectively.

...
Published: 19 Feb 2018

The MNI forms promising Open Science partnership with Takeda

Industry and academia team up for the benefit of people suffering from ALS

A unique industry-academia partnership will increase the rate at which promising drug compounds can be tested as potential treatments for amyotrophic lateral sclerosis (ALS), a disease with no known cure that affects 200,000 people worldwide.

...
Published: 4 Dec 2017

Pages